Market Opportunity
Currently, there are limited number of approved treatment options for fibromyalgia. Several
manufacturers have potential candidates in the pipeline (some in late stages as well). Hence,
new players in the market also have opportunity to develop new drug candidate for treatment
of fibromyalgia.
Browse Complete Report For More Information @
https://www.coherentmarketinsights.com/market-insight/fibromyalgia-treatment-market-1691
Another opportunity is present in terms of generic drug manufacturing, as two of the drugs are
expected to lose patent protection over the forecast period (Lyrica in 2019 and Savella in 2021,
2023, and 2029). Patent loss may be a restraint for the market, however, there is certainly an
opportunity for generic manufacturers.
Key players operating in the fibromyalgia treatment market include Eli Lilly and Company,
Pfizer, Inc., Novartis AG, Allergan plc, Sun Pharmaceutical Industries Ltd., Aptinyx, Inc.,
Prismic Pharmaceuticals, Inc., Innovative Med Concepts, Inc., Intec Pharma Ltd., and Astellas
Pharma Inc.
About Coherent Market Insights
Coherent Market Insights is a prominent market research and consulting firm offering action-
ready syndicated research reports, custom market analysis, consulting services, and competitive
analysis through various recommendations related to emerging market trends, technologies, and
potential absolute dollar opportunity.
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702